Physician

Charbel Antoine Salem, M.D.

According to 2025 Medicare claims, Charbel Salem, M.D. (NPI: 1881851087) practices nephrology in the Huntington-Ashland, WV-KY-OH market, with the plurality of this provider's patient population coming from Boyd, KY. This provider's primary affiliated billing organization is KINGS DAUGHTERS MEDICAL SPECIALTIES INC (NPI: 1184912453; TIN: 264183569) and primary practice location at 41101-2843.

Salem's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 602 traditional Medicare patients, billed 1,598 HCPCS/CPT codes, and received $131,072 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 1,002 prescription claims across 248 beneficiaries totaling $161,184 in drug costs, led by Tolvaptan (Tolvaptan). 2019 DME data shows 24 claims. Open Payments data shows 12 records totaling $233. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $244,636 to $131,072. Similarly, Part D prescription costs have declined steadily, from $342,060 to $161,184. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,129	3,377	$244,636
2016	1,208	3,546	$271,755
2017	1,014	3,163	$237,011
2018	933	2,674	$195,562
2019	935	2,822	$196,650
2020	678	2,582	$185,330
2021	625	2,378	$184,365
2022	637	2,189	$178,284
2023	605	1,757	$153,802
2024	602	1,598	$131,072

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	381	3,511	$342,060
2016	445	3,663	$438,070
2017	372	3,422	$534,240
2018	316	2,309	$395,583
2019	314	2,097	$353,084
2020	284	1,907	$525,177
2021	276	1,618	$329,797
2022	273	1,204	$226,147
2023	256	1,134	$289,018
2024	248	1,002	$161,184

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	54	$1,950
2017	N/R	82	$3,085
2018	N/R	12	$138
2019	N/R	24	$694
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	89	93	$126
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	34	36	$95
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	88	88	$89
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	233	318	$62
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	278	817	$58

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tolvaptan	Tolvaptan	11	315	$48,105
Auryxia	Ferric Citrate	31	1,170	$31,328
Velphoro	Sucroferric Oxyhydroxide	11	330	$27,848
Eliquis	Apixaban	11	330	$6,433
Sevelamer Carbonate	Sevelamer Carbonate	56	3,240	$5,772

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	12	$233	AKEBIA THERAPEUTICS INC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Charbel Antoine Salem, M.D.?

Tedicare shows public-source Medicare data for Charbel Antoine Salem, M.D. (NPI 1881851087), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Charbel Antoine Salem, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Charbel Antoine Salem, M.D.?

Charbel Antoine Salem, M.D. is linked to KINGS DAUGHTERS MEDICAL SPECIALTIES INC (billing NPI 1184912453) in the available physician profile data.

Does Charbel Antoine Salem, M.D. have Open Payments data?

Charbel Antoine Salem, M.D. has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.